JNJ vs. KVUE
JNJ (Johnson & Johnson) and KVUE (Kenvue Inc.) are both stocks. JNJ operates in Drug Manufacturers - General (Healthcare), while KVUE operates in Household & Personal Products (Consumer Defensive). Over the past 3 years, JNJ returned 16.30%/yr vs -8.81%/yr for KVUE. At a 0.31 correlation, their price movements are largely independent.
Performance
JNJ vs. KVUE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, JNJ achieves a 11.48% return, which is significantly higher than KVUE's 0.17% return.
JNJ
- 1D
- 2.21%
- 1M
- 1.74%
- YTD
- 11.48%
- 6M
- 13.94%
- 1Y
- 52.64%
- 3Y*
- 16.30%
- 5Y*
- 9.61%
- 10Y*
- 9.99%
KVUE
- 1D
- 0.30%
- 1M
- -1.65%
- YTD
- 0.17%
- 6M
- 1.70%
- 1Y
- -18.53%
- 3Y*
- -8.81%
- 5Y*
- —
- 10Y*
- —
JNJ vs. KVUE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
JNJ Johnson & Johnson | 11.48% | 47.48% | -4.81% | -1.10% |
KVUE Kenvue Inc. | 0.17% | -15.86% | 3.12% | -18.44% |
Correlation
The correlation between JNJ and KVUE is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.32 |
Correlation (All Time) Calculated using the full available price history since May 5, 2023 | 0.31 |
Fundamentals
JNJ:
$557.92B
KVUE:
$32.44B
JNJ:
$8.65
KVUE:
$0.84
JNJ:
26.38
KVUE:
20.01
JNJ:
5.76
KVUE:
2.12
JNJ:
6.87
KVUE:
3.06
JNJ:
$96.36B
KVUE:
$15.29B
JNJ:
$66.60B
KVUE:
$8.93B
JNJ:
$31.62B
KVUE:
$3.03B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JNJ vs. KVUE — Risk / Return Rank
JNJ
KVUE
JNJ vs. KVUE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Johnson & Johnson (JNJ) and Kenvue Inc. (KVUE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| JNJ | KVUE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.74 | ||
| Sortino ratioReturn per unit of downside risk | +5.23 | ||
| Omega ratioGain probability vs. loss probability | 1.57 | 0.91 | +0.66 |
| Calmar ratioReturn relative to maximum drawdown | 4.83 | -0.49 | +5.32 |
| Martin ratioReturn relative to average drawdown | 14.43 | -0.92 | +15.35 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| JNJ | KVUE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.16 | -0.58 | +3.74 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.57 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.54 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.54 | -0.37 | +0.91 |
Drawdowns
JNJ vs. KVUE - Drawdown Comparison
The maximum JNJ drawdown since its inception was -50.67%, which is greater than KVUE's maximum drawdown of -44.08%. Use the drawdown chart below to compare losses from any high point for JNJ and KVUE.
Loading charts...
Drawdown Indicators
| JNJ | KVUE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -50.67% | -44.08% | -6.59% |
Max Drawdown (1Y)Largest decline over 1 year | -10.96% | -37.63% | +26.67% |
Max Drawdown (3Y)Largest decline over 3 years | -15.95% | -42.08% | +26.13% |
Max Drawdown (5Y)Largest decline over 5 years | -18.41% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -27.37% | — | — |
Current DrawdownCurrent decline from peak | -7.68% | -30.66% | +22.98% |
Average DrawdownAverage peak-to-trough decline | -11.88% | -21.00% | +9.12% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.66% | 20.26% | -16.60% |
Volatility
JNJ vs. KVUE - Volatility Comparison
Johnson & Johnson (JNJ) and Kenvue Inc. (KVUE) have volatilities of 5.62% and 5.52%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| JNJ | KVUE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.62% | 5.52% | +0.10% |
Volatility (6M)Calculated over the trailing 6-month period | 12.35% | 13.44% | -1.09% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.77% | 32.04% | -15.27% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.85% | 28.59% | -11.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.45% | 28.59% | -10.14% |
Dividends
JNJ vs. KVUE - Dividend Comparison
JNJ's dividend yield for the trailing twelve months is around 2.30%, less than KVUE's 4.92% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JNJ Johnson & Johnson | 2.30% | 2.48% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% |
KVUE Kenvue Inc. | 4.92% | 4.78% | 3.79% | 1.86% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
JNJ vs. KVUE - Financials Comparison
This section allows you to compare key financial metrics between Johnson & Johnson and Kenvue Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
JNJ vs. KVUE - Profitability Comparison
JNJ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a gross profit of 17.20B and revenue of 24.06B. Therefore, the gross margin over that period was 71.5%.
KVUE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Kenvue Inc. reported a gross profit of 2.30B and revenue of 3.91B. Therefore, the gross margin over that period was 58.9%.
JNJ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported an operating income of 6.40B and revenue of 24.06B, resulting in an operating margin of 26.6%.
KVUE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Kenvue Inc. reported an operating income of 767.00M and revenue of 3.91B, resulting in an operating margin of 19.6%.
JNJ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a net income of 5.24B and revenue of 24.06B, resulting in a net margin of 21.8%.
KVUE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Kenvue Inc. reported a net income of 474.00M and revenue of 3.91B, resulting in a net margin of 12.1%.
Frequently Asked Questions
JNJ and KVUE have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
JNJ has higher volatility (5.62%) compared to KVUE (5.52%). In terms of maximum drawdown, JNJ dropped -50.67% vs KVUE's -44.08%.
JNJ currently has the higher Sharpe Ratio (3.16 vs -0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for JNJ and KVUE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer